ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Assessment Questionnaire (HAQ)"

  • Abstract Number: 0145 • ACR Convergence 2020

    Treat-to-Target in Rheumatoid Arthritis: Rates of Treatment Changes in Patients Engaged with Care Management Services Compared to Historically Reported National Registry Based Estimates

    Pranav Patel1, Andrew Krueger2, Aliza Lipson3, Michele Hamburger4 and Craig Hunter5, 1CVS Health, Toledo, OH, 2Accordant Health Services, Greensboro, NC, 3Emory University, Palmetto Bay, FL, 4Frances Hamburger Institute, Hauppauge, NY, 5CVS Health, Northbrook

    Background/Purpose: Treat-to-target is the foundation of rheumatoid arthritis (RA) management. Prioritizing routine measurement of patient-reported disease activity along with conventional physician, laboratory and imaging assessments…
  • Abstract Number: 0153 • ACR Convergence 2020

    Counseling on Safe Driving Strategies in Patients with Osteoarthritis and Rheumatoid Arthritis

    Anna Falls1, Peta-Gay Ricketts1, John Elliott1 and Kim Jordan1, 1OhioHealth Riverside Methodist Hospital, Columbus, OH

    Background/Purpose: Osteoarthritis (OA) and rheumatoid arthritis (RA) cause functional impairments that impact daily life activities, including automobile driving. Radiographic presence of OA on knee and…
  • Abstract Number: 0329 • ACR Convergence 2020

    Healthcare Utilization and Costs Associated with Functional Status in Patients with Psoriatic Arthritis

    Alexis Ogdie1, Mark Hwang2, Phani Veeranki3, Alexandria Portelli3, Steven Sison3, Jason Shafrin3, Sofia Pedro4, Peter Hur5, Nina Kim6 and Kaleb Michaud7, 1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 3PRECISIONheor, Los Angeles, 4FORWARD-The National Data Bank for Rheumatic Diseases, Wichita, 5Novartis Pharmaceuticals Corporation, East Hanover, NJ, 6The University of Texas at Austin; Baylor Scott and White Health, Austin, TX, 7FORWARD-The National Data Bank for Rheumatic Diseases; University of Nebraska Medical Center, Wichita

    Background/Purpose: The Health Assessment Questionnaire Disability Index (HAQ-DI) has been validated and widely used in psoriatic arthritis (PsA) clinical trials for the assessment of patient…
  • Abstract Number: 0536 • ACR Convergence 2020

    Systematic Geriatric Assessment in Older Patients with Rheumatic Diseases – The RheuMAGIC Pilot Study

    Bjoern Buehring1, Anna Berrisch2, Ioana Andreica3, Styliani Tsiami4, David Kiefer3, Uta Kiltz2, Xenofon Baraliakos2 and Juergen Braun2, 1Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Velbert, Germany, 2Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany

    Background/Purpose: Current demographic data predict that the number of older adults with rheumatic diseases will considerably increase in the coming years. Geriatric patients differ from…
  • Abstract Number: 0758 • ACR Convergence 2020

    Anti-citrullinated Protein Antibodies Are Associated with Functional Disability in Unaffected First-degree Relatives of Rheumatoid Arthritis Patients

    Dana Wiens1, Irene Smolik1, Xiaobo Meng1, Vidyanand Anaparti1, Hani El-Gabalawy1 and Liam O'Neil1, 1University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose: The preclinical stage of Rheumatoid Arthritis (RA) is characterized by seropositivity for anti-citrullinated protein antibodies (ACPA). We (PubMed ID 30861615), and others, have shown that ACPA seropositivity…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology